N. Willmott

1.7k total citations
64 papers, 1.3k citations indexed

About

N. Willmott is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N. Willmott has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N. Willmott's work include Nanoparticle-Based Drug Delivery (10 papers), Cancer Treatment and Pharmacology (10 papers) and Advanced Drug Delivery Systems (9 papers). N. Willmott is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Cancer Treatment and Pharmacology (10 papers) and Advanced Drug Delivery Systems (9 papers). N. Willmott collaborates with scholars based in United Kingdom, United States and Japan. N. Willmott's co-authors include Jeffrey L. Cummings, Alastair J. Florence, John F. Smyth, CS McArdle, DJ Kerr, Lorraine Anderson, Alan Rogerson, J. H. McKillop, Joseph C. Anderson and Yan Chen and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

N. Willmott

62 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Willmott United Kingdom 20 458 391 297 221 152 64 1.3k
T Ohnuma United States 16 554 1.2× 812 2.1× 83 0.3× 354 1.6× 202 1.3× 40 1.7k
Dana Masin Canada 25 1.3k 2.8× 532 1.4× 195 0.7× 1.1k 5.2× 97 0.6× 37 2.2k
Dawn Waterhouse Canada 20 704 1.5× 308 0.8× 95 0.3× 568 2.6× 76 0.5× 36 1.4k
A. Trouet Belgium 21 749 1.6× 422 1.1× 90 0.3× 220 1.0× 62 0.4× 76 1.6k
M F Poupon France 22 620 1.4× 607 1.6× 67 0.2× 238 1.1× 168 1.1× 48 1.5k
Alberto Gabizon Israel 16 754 1.6× 342 0.9× 140 0.5× 840 3.8× 106 0.7× 23 1.6k
Gerald J. Fetterly United States 24 901 2.0× 609 1.6× 52 0.2× 264 1.2× 378 2.5× 88 1.9k
Donald J. Dykes United States 16 681 1.5× 743 1.9× 76 0.3× 383 1.7× 238 1.6× 27 1.7k
Paul Tardi Canada 25 1.4k 3.0× 474 1.2× 152 0.5× 1.2k 5.6× 98 0.6× 52 2.5k
Run Lin China 19 383 0.8× 390 1.0× 77 0.3× 394 1.8× 175 1.2× 46 1.5k

Countries citing papers authored by N. Willmott

Since Specialization
Citations

This map shows the geographic impact of N. Willmott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Willmott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Willmott more than expected).

Fields of papers citing papers by N. Willmott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Willmott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Willmott. The network helps show where N. Willmott may publish in the future.

Co-authorship network of co-authors of N. Willmott

This figure shows the co-authorship network connecting the top 25 collaborators of N. Willmott. A scholar is included among the top collaborators of N. Willmott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Willmott. N. Willmott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willmott, N. & J.M. Daly. (2020). Microspheres and Regional Cancer Therapy.
2.
Willmott, N. & J.M. Daly. (2020). Microspheres and Regional Cancer Therapy.
3.
Wang, Xiaoen, N. Willmott, Surinder K. Chander, et al.. (1997). Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clinical & Experimental Metastasis. 15(2). 184–195. 48 indexed citations
4.
Chander, Surinder K., Pari Antoniw, Nigel R. A. Beeley, et al.. (1995). An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase A. Journal of Pharmaceutical Sciences. 84(4). 404–409. 10 indexed citations
5.
Cummings, Jeffrey L., et al.. (1993). Incorporation and Release of Chemically Intact Mitomycin C from Albumin Microspheres: a High Performance Liquid Chromatography Evaluation. Journal of drug targeting. 1(4). 317–324. 6 indexed citations
6.
Anderson, JH, Wilson J. Angerson, N. Willmott, et al.. (1992). Is there a relationship between regional microsphere distribution and hepatic arterial blood flow?. British Journal of Cancer. 66(2). 287–289. 5 indexed citations
7.
Cummings, Jeffrey L., et al.. (1992). The consequences of doxorubicin quinone reduction in vivo in tumour tissue. Biochemical Pharmacology. 44(11). 2165–2174. 40 indexed citations
8.
Willmott, N., et al.. (1992). An in vivo assessment of adriamycin-loaded albumin microspheres. British Journal of Cancer. 65(3). 393–395. 6 indexed citations
9.
Cummings, Jeffrey L., et al.. (1992). The enzymology of doxorubicin quinone reduction in tumour tissue. Biochemical Pharmacology. 44(11). 2175–2183. 36 indexed citations
10.
Anderson, JH, et al.. (1991). Regional chemotherapy for inoperable renal carcinoma: a method of targeting therapeutic microspheres to tumour. British Journal of Cancer. 64(2). 365–368. 8 indexed citations
11.
Watson, David G., et al.. (1991). The analysis of 5-fluorouracil in human plasma by gas chromatography—negative ion chemical ionization mass spectrometry (GC—NICIMS) with stable isotope dilution. Journal of Pharmaceutical and Biomedical Analysis. 9(1). 19–21. 13 indexed citations
12.
McCurrach, G., et al.. (1991). Arteriovenous shunting in patients with colorectal liver metastases. British Journal of Cancer. 63(3). 466–468. 10 indexed citations
13.
Goldberg, J A, N. Willmott, G. McCurrach, et al.. (1991). The biodegradation of albumin microspheres used for regional chemotherapy in patients with colorectal liver metastases. Nuclear Medicine Communications. 12(1). 57–64. 12 indexed citations
14.
Willmott, N., T. Murray, Yang Chen, et al.. (1991). Development of radiolabelled albumin microspheres: a comparison of gamma-emitting radioisotopes of iodine (131I) and indium (111In/113mIn). International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(7). 687–694. 2 indexed citations
15.
Cummings, Jeffrey L., Lorraine Anderson, N. Willmott, & John F. Smyth. (1991). The molecular pharmacology of doxorubicin in vivo. European Journal of Cancer and Clinical Oncology. 27(5). 532–535. 128 indexed citations
16.
Kerr, DJ, et al.. (1990). The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases. British Journal of Cancer. 61(6). 913–915. 17 indexed citations
17.
Kerr, DJ, N. Willmott, J. H. McKillop, et al.. (1988). Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration. Cancer. 62(5). 878–883. 19 indexed citations
18.
Willmott, N.. (1987). Chemoembolisation in regional cancer chemotherapy: a rationale. Cancer Treatment Reviews. 14(2). 143–156. 16 indexed citations
19.
Bradnam, Michael S., David Kerr, J. H. McKillop, et al.. (1987). Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases. Nuclear Medicine Communications. 8(12). 1025–1032. 19 indexed citations
20.
Willmott, N., Eric Austin, & R W Baldwin. (1979). Comparative studies of the metastatic potential of three transplantable rat mammary carcinomas of spontaneous origin.. PubMed Central. 60(5). 499–506. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Ohnuma Breakdown of academic impact, for papers by Dana Masin Breakdown of academic impact, for papers by Dawn Waterhouse Breakdown of academic impact, for papers by A. Trouet Breakdown of academic impact, for papers by M F Poupon Breakdown of academic impact, for papers by Alberto Gabizon Breakdown of academic impact, for papers by Gerald J. Fetterly Breakdown of academic impact, for papers by Donald J. Dykes Breakdown of academic impact, for papers by Paul Tardi Breakdown of academic impact, for papers by Run Lin
Rankless by CCL
2026